Podcasts
Episode 232: Managing Fatigue During PARP Inhibitor Maintenance Therapy
“For those without cancer or other illnesses, we often have a resolution or relief of this fatigue. ‘Oh, I’m just going to go to bed early and get a couple more hours of sleep tonight.’ Or ‘I’m going to have a cup of coffee.’ But for people with cancer, it’s not an easy fix. People with cancer describe fatigue as something much more long-lasting,” ONS member Paula Anastasia, MN, RN, AOCN®, clinical nurse specialist for UCLA Health in Los Angeles, CA, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Anastasia discussed fatigue in patients with cancer undergoing PARP inhibitor maintenance therapy, management strategies, and nursing considerations. This podcast episode is supported by a sponsorship from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.